• Thu. Oct 6th, 2022

Lara Goldstein

  • Home
  • Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes

Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes

A recent study published by life sciences company Grace Health & Wellness aims to raise awareness on the possibility of using medical cannabis and psychedelics to propel traditional pharmaceuticals. The…

Can Ketamine Treat Alcohol Addiction? Clinics & Hospitals In Europe And North America Are Already Doing It – Awakn Life Sciences (OTC:AWKNF)

(Part one of a four-part series) The use of psychedelic-assisted psychotherapy for the treatment of mental health conditions has become a hot topic, with a growing general sense of acceptance, public discussion…

Maine Survey Shows Most Voters Want A New Drug Policy Approach That Includes Decriminalization

A recent poll, led by University of Maine professors R. Glover and K. Sporer during July and August 2021 and shared this week, found that of the 400+ Mainers, a majority believe…

PharmaTher Provides Business Highlights And Releases Audited Annual Financials – PharmaTher Holdings (OTC:PHRRF)

PharmaTher Holdings Ltd. PHRRF has published its operational and audited financial results for fiscal year ended May 31, 2022.  The company, which focuses on delivering ketamine for treating mental health disorders  closed the…

Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives – BetterLife Pharma (OTC:BETRF)

In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings. The emerging biotech BetterLife Pharma Inc. BETRF has filed an international PCT along with…

Psychedelics Capital Markets: Silo Pharma’s IPO, $5M Common Stock Offering – (SILO)

Developmental-stage biopharma company Silo Pharma Inc. SILO announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $5.00 per share, to begin trading on…

Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System – Biomind Labs (OTC:BMNDF)

Life and sciences R&D company Biomind Labs Inc. BMNDF received a Controlled Substances License to begin an eight-month exclusive collaboration with Queen’s University of Belfast to produce and evaluate rapidly-dissolving and…

Psychedelics Biotechs Clearmind And Mydecine Share Consolidation And Subscription Agreements – Clearmind Medicine (OTC:CMNDF), Mydecine Innovations Gr (OTC:MYCOF)

In connection with recent stock splits, psychedelics biotech Clearmind Medicine Inc. CMNDF announced it will proceed with the consolidation of all its issued and outstanding common shares on a 1:30 basis,…

Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder? – Tryp Therapeutics (OTC:TRYPF)

Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. TRYPF filed two provisional patent applications – one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP.   Tryp’s Psilocybin-For-Neuropsychiatric Disorders (PFN)…

Magic Mushrooms For Anorexia? Clinical Study Receives FDA Approval For Phase 2 Trial

Origin Therapeutics Holdings Inc. ORIG, a psychedelics industry-focused investment issuer, announced that one of its portfolio companies, Xpira Pharmaceuticals, has obtained approval from the FDA for its first Investigational New Drug (IND) application for a Phase 2a…

Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage – Biomind Labs (OTC:BMNDF)

Biomind Labs Inc. BMNDF, a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of DMT-based proprietary drug…

Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic – Delic Hldgs (OTC:DELCF), Numinus Wellness (OTC:NUMIF)

Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada.  Numinus Wellness Inc. NUMIF announced the opening of a second Canada-based clinic in…

Canada Studies Effects Of Psilocybin For COVID Frontline Healthcare Workers In Phase 2 Clinical Trial

Alberta-based ATMA Journey Centers Inc. has received Health Canada’s approval to move forward with its N500 Phase II psilocybin clinical study investigating the potential relief of COVID-19-associated mental health challenges…

Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year – Awakn Life Sciences (OTC:AWKNF)

Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. AWKNF has announced its financial outcomes and business highlights for the three months ended July 31, 2022.…

New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details – Nova Mentis Life Science (OTC:NMLSF)

Canadian-based psychedelics company Nova Mentis Life Science Corp. NMLSF, or NOVA, is collaborating with the Toronto Institute of Pharmaceutical Technology (TIPT), a Health Canada-licensed GMP manufacturing and testing facility, to complete the production…

Psychedelics Startups Thrive As Seed Funding Grows: Healing Maps Raises $1M

HealingMaps, an informative psychedelic therapy search site, announced the closing of a seed round funding for a total $1 million coming from eight investors including Phyto Partners and Ambria Capital. …

Psychedelics Decriminalization In Oregon: An Update On Voters’ Stance

Oregon voters said yes to all-psychedelics possession decriminalization in 2020’s state ballot, and a recent poll by Data for Progress showed that the majorly stand by Measure 110’s original approval. The new survey…

Numinus Wellness (OTC:NUMIF), Tryp Therapeutics (OTC:TRYPF), Small Pharma (OTC:DMTTF) – Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma

Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. NUMIF recently acquired psychedelics company Novamind and is successfully integrating its activities: US clinics performed solidly while…

MAPS Gets A New Partner To Study MDMA Therapy In Patients With PTSD

In recent months, the psychedelics space has been ground for increasing collaborations. In some cases it was to advance scientific studies. In others, to offer psychedelic medicine, therapy training and clinical…

Awakn Life Sciences (OTC:AWKNF), Revitalist Lifestyle (OTC:RVLWF) – Psychedelics Companies Are Teaming Up To Offer Access Veterans

Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on  access needs for veterans.  The…

Atlanta Is Considering The Decriminalization Of Magic Mushrooms And Other Psychedelics

The growing demand for better treatments for mental health conditions is taking the discussion to the public sphere often than not.  With San Francisco’s final call to decriminalize psychedelics last week,…

(CSE:NIRV) – Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds

Nirvana Life Sciences Inc. NIRV announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds. The 3-step synthesis starts from the MDMA precursor safrole and takes only 24…

Newscope Capital (PHRRF) – Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

PharmaTher Holdings PHRRF, the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch,…

Optimi Health (OPTHF) – Psychedelic Mushrooms Are Going Global: Supply Deal With UK-Based Wellness Company Moves Forward

Expert functional and magic mushrooms grower Optimi Health Corp. OPTHF has signed an agreement with Avida Global, a privately-held UK-based producer of white label products including nutraceuticals and medicinal cannabis…

Mindset Pharma (MSSTF) – Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries

Psychedelics R&D company Mindset Pharma MSSTF has filed no less than 16 national applications, including countries within the main South East Asian markets, for one of its key families of…